RVL Pharmaceuticals PLC RVLP

Market cap
$14.1M
P/E
0.0×
Jun '23 Mar '23 Dec '22 Sep '22 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.51 3.05 2.08 4.55
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(4.61) (19.46) (6.28) (19.29)
P/B ratio
3.41 2.83 2.02 2.84
EV/Sales
2.55 3.71 2.33 4.48
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(1.99) (4.26) (3.00) (4.20)
Current Ratio
0.38 2.34 2.89 3.30
Net Debt/EBITDA
(4.81) (2.41) (1.54) 0.24
Debt/Equity
3.54 1.43 1.11 0.82
Earnings Yield
(125.00%) (52.63%) (48.70%) (29.52%)
Free Cash Flow Yield
(85.20%) (28.56%) (37.34%) (23.43%)
Free Cash Flow per Share
(0.13) (0.07) (0.19) (0.11)
Book value per Share
0.16 0.40 0.57 0.74
Free Cash Flow
(13.02) (7.04) (17.48) (9.87)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates